Novus International, Inc. has been selected to receive the 2012 North American New Product Innovation Award in Prebiotics for PREVIDA®. The award is presented by Frost & Sullivan, a 50-year old global research organization of 1,800 analysts and consultants who monitor more than 300 industries and 250,000 companies.
"Novus is proud to receive such a prestigious award from Frost & Sullivan," stated Thad Simons, President and CEO, at Novus. "We're equally humbled by this recognition because our mission is not to seek awards for what we do; rather it is to focus on sustainably meeting the growing global need for health and nutrition. We're excited about offering our customers the health and nutrition solutions associated with feeding PREVIDA."
Frost & Sullivan's selection of PREVIDA was the result of a decision support matrix (DSM) comprised of five criteria, including 1) Innovative Element of the Product, 2) Leverage of Leading-Edge Technologies, 3) Value Added Features/Benefits, 4) Increased Customer ROI and 5) Customer Acquisition/Penetration Potential. Frost & Sullivan concluded that PREVIDA was truly an innovative product with immense market penetration potential.
Frost & Sullivan's research philosophy originates with the CEO's 360-Degree Perspective™, which serves as the foundation of its TEAM Research™ methodology. "This unique approach enables us to determine how best-in-class companies worldwide manage growth, innovation and leadership," noted Aarthi Janakiraman, Senior Research Analyst at Frost & Sullivan. "Based on the findings of this Best Practice research, we're delighted to present the 2012 North American New Product Innovation Award in Prebiotics for Animal Health to Novus."
PREVIDA is a unique prebiotic comprised of an all-natural, hemicellulose extract that promotes intestinal health for a variety of species. The product contains a high level of soluble dietary fiber in the form of specific oligosaccharides, which have been shown to provide compelling digestive health benefits. Studies suggest PREVIDA impacts gut microflora and significantly improves immune response leading to healthier, more resilient livestock.
PREVIDA was discovered by research scientists at Temple-Inland, a wood products company. After Temple-Inland assessed the nutritional profile and health benefits of the product, they reached out to Novus for its expertise in developing animal health and nutrition solutions. Novus has the exclusive global marketing and distribution rights for PREVIDA.
"Preliminary studies indicate that PREVIDA promises to be a Prebiotic with increasing health and nutrition benefits for all livestock," said Ted Toburen, Senior Director Therapeutic Nutrition Solutions, at Novus. "We're excited about offering another solution to our livestock customers in helping them optimize the health of their animals."
Novus will attend a special awards ceremony, hosted by Frost & Sullivan, in San Jose, CA in September 2012 where they will be presented with the award.
For more information visit www.novusint.com